News

In a matter of years, a non-addictive pharmaceutical could be on the market, and the company developing the medication is right here in Pittsburgh. Click to View Article

Third Pole Therapeutics CEO Bill Athenson sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. Click to View Article

A partnership announced by the bank and YieldStreet Inc. on Wednesday will make about $2 billion of assets available to the platform’s mass affluent investors, according to people with knowledge of the deal’s size. Click to View Article

Digital wealth management platform company YieldStreet recently announced the acquisition of WealthFlex. These are the details. Click to View Article

Knopp Biosciences LLC and the University of Leicester today announced timelines, trial details, and eligibility criteria for a planned Phase 2 clinical trial evaluating the oral eosinophil-lowering drug candidate dexpramipexole in severe eosinophilic asthma patients that is on track to … Continued

hird Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. Click to View Article

In a matter of years, people with chronic conditions may not have to choose between pain relief and risking addiction. Click to View Article

Matt Pohlson, 41, is chief executive and co-founder of Omaze, a for-profit online fundraising company in Culver City that raffles off unique celebrity experiences and prizes to support charitable efforts and help fund nonprofits. Click to View Article

Knopp is advancing lead Kv7 platform candidate toward clinical studies in a rare pediatric epilepsy Click to View Article

Leading video platform provider sets new high-water mark for bookings, renewal, customer viewership, and company expansion. Click to View Article